Literature DB >> 30817071

Genetic variants of VWF gene in type 2 von Willebrand disease.

Samuel da Silva Freitas1,2, Suely Meireles Rezende2, Luciana Correa de Oliveira3, Alessandra Nunes Loureiro Prezotti4, Marília Sande Renni5, Camila Amormino Corsini1, Marcos Vinícius de Almeida Amorim1, Carolina Guimarães Ramos Matosinho6, Maria Raquel Santos Carvalho6, Daniel Gonçalves Chaves1.   

Abstract

INTRODUCTION: von Willebrand disease (VWD) is the most common inherited bleeding disorder. Few studies have explored the molecular basis of type 2 VWD. AIM: This study aimed to identify variants associated with type 2 VWD.
METHODS: We collected clinical and laboratory data, as well as response to desmopressin and bleeding assessment tool (BAT) score in patients diagnosed with type 2 VWD. We sequenced exons 17, 18, 20 and 28 of the VWF gene.
RESULTS: We identified 19 different variants in 40 unrelated patients (47.5%). Most of the variants (84.2%) were found in exon 28. A total of 10/19 variants (52.6%) were identified as "likely causative" in 17/40 patients (42.5%), according to the ISTH-SSC and EAHAD VWF gene mutations databases. Nine variants were initially identified as potentially benign. However, through analyses in silico, four of these variants were reclassified as "likely pathogenic" (Ile1380Val, Asn1435Ser, Ser1486Leu and Tyr1584Cys). Response to desmopressin was associated with three variants: Met740Ile, Arg1597Gln and Tyr1584Cys. Major bleeding was associated with variants related to VWD subtypes 2B and 2M.
CONCLUSION: In conclusion, we identified 19 variants, of which 14 are "likely pathogenic" and therefore associated with VWD. We suggest a possible association of pathogenic variants with major bleeding, response to desmopressin and BAT score ≥10, although this requires further confirmation.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  bleeding; gene; genetic variants; sequencing; von Willebrand disease

Mesh:

Substances:

Year:  2019        PMID: 30817071     DOI: 10.1111/hae.13714

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

Review 2.  A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis.

Authors:  Steven Bell; Andreas S Rigas; Magnus K Magnusson; Egil Ferkingstad; Elias Allara; Gyda Bjornsdottir; Anna Ramond; Erik Sørensen; Gisli H Halldorsson; Dirk S Paul; Kristoffer S Burgdorf; Hannes P Eggertsson; Joanna M M Howson; Lise W Thørner; Snaedis Kristmundsdottir; William J Astle; Christian Erikstrup; Jon K Sigurdsson; Dragana Vuckovic; Khoa M Dinh; Vinicius Tragante; Praveen Surendran; Ole B Pedersen; Brynjar Vidarsson; Tao Jiang; Helene M Paarup; Pall T Onundarson; Parsa Akbari; Kaspar R Nielsen; Sigrun H Lund; Kristinn Juliusson; Magnus I Magnusson; Michael L Frigge; Asmundur Oddsson; Isleifur Olafsson; Stephen Kaptoge; Henrik Hjalgrim; Gudmundur Runarsson; Angela M Wood; Ingileif Jonsdottir; Thomas F Hansen; Olof Sigurdardottir; Hreinn Stefansson; David Rye; James E Peters; David Westergaard; Hilma Holm; Nicole Soranzo; Karina Banasik; Gudmar Thorleifsson; Willem H Ouwehand; Unnur Thorsteinsdottir; David J Roberts; Patrick Sulem; Adam S Butterworth; Daniel F Gudbjartsson; John Danesh; Søren Brunak; Emanuele Di Angelantonio; Henrik Ullum; Kari Stefansson
Journal:  Commun Biol       Date:  2021-02-03

3.  Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.

Authors:  Ivana Lapić; Margareta Radić Antolic; Ana Boban; Desiree Coen Herak; Dunja Rogić; Renata Zadro
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.